IL-2, IL-5, TNF-α and IFN-γ mRNA expression in epidermal keratinocytes of systemic lupus erythematosus skin lesions

Clinics

Volumn 66, Issue 1, 2011, Pages 77-82

  Carneiro, José Ronaldo M ^a   Fuzii, Hellen T ^a   Kayser, Cristiane ^b,c   Alberto, Fernando L ^c   Soares, Fernando A ^d   Sato, Emília I ^b   Andrade, Luís Eduardo C ^b  

^a FEDERAL UNIVERSITY OF PARÁ   (Brazil)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^c Fleury   (Brazil)

^d Cancer Hospital   (Brazil)

Author keywords

Cytokines; Gene expression; Interleukins; Lupus

Indexed keywords

CYTOKINE; MESSENGER RNA;

ADULT; ARTICLE; FEMALE; GENE EXPRESSION; GENETICS; HUMAN; KERATINOCYTE; MALE; METABOLISM; MIDDLE AGED; POLYMERASE CHAIN REACTION; SKIN DISEASE; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; CYTOKINES; FEMALE; GENE EXPRESSION; HUMANS; KERATINOCYTES; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; RNA, MESSENGER; SKIN DISEASES; YOUNG ADULT;

EID: 79952956550     PISSN: 18075932     EISSN: None     Source Type: Journal    
DOI: 10.1590/S1807-59322011000100014     Document Type: Article

References (22)

1. Wallace DJ. The clinical presentation of systemic lupus erythematosus. In: Wallace DJ, Hahn BH, editors, Dubois' Lupus Erythematosus. London: William & Wilkins; 2007. p 638-46.
2. Sontheimer RD, McCauliffe DP. Lupus-specific skin disease. In: Wallace DJ, Hahn BH, editors, Dubois' Lupus Erythematosus. London: William & Wilkins; 2007. p 576-620.
3. Yamamura M, Uyemura K, Deans RJ, Weinberg K, Rea TH, Bloom BR, et al. Defining protective responses to pathogens: cytokine profiles in leprosy lesions. Science. 1991;254:277-9, doi: 10.1126/science.1925582.
4. Uyemura K, Yamamura M, Fivenson DF, Modlin RL, Nickoloff BJ. The cytokine network in lesional and lesion-free psoriatic skin is characterized by a T-helper type 1 cell-mediated response. J Invest Dermatol. 1993;101:701-5, doi: 10.1111/1523-1747.ep12371679.
5. Saed G, Fivenson DP, Naidu Y, Nickoloff BJ. Mycosis fungoides exhibits a Th1-type cell-mediated cytokine profile whereas Sezary syndrome expresses a Th2-type profile. J Invest Dermatol. 1994;103:29-33, doi: 10. 1111/1523-1747.ep12388985.
6. Nürnberg W, Haas N, Schadendorf D, Czarnetzki BM. Interleukin-6 expression in the skin of patients with lupus erythematosus. Exp Dermatol. 1995;4:52-7, doi: 10.1111/j.1600-0625.1995.tb00222.x.
7. Stein LF, Saed GM, Fivenson DP. T-cell cytokine network in cutaneous lupus erythematosus. J Am Acad Dermatol. 1997;36:191-6, doi: 10.1016/S0190-9622(97)70279-2.
8. Toro JR, Finlay D, Dou X, Zheng SC, LeBoit PE, Connolly MK. Detection of type 1 cytokines in discoid lupus erythematosus. Arch Dermatol. 2000;136:1497-501, doi: 10.1001/archderm.136.12.1497.
9. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1982;25:1271-7, doi: 10.1002/art. 1780251101.
10. Bonner CF, Emmert-Buck M, Cole K, Pohida T, Chuaqui R, Goldstein S. Laser capture microdissection: molecular analysis of tissue. Science. 1997;278:1481-3, doi: 10.1126/science.278.5342.1481.
11. Pfaffl MW. A new mathematical model for relative quantification in realtime RT-PCR. Nucleic Acids Res. 2001;29:e45, doi: 10.1093/nar/29.9. e45",-1,"xxx/9.e45.
12. Wood LC, Jackson SM, Elias PM, Grunfeld C, Feingold KR. Cutaneous barrier perturbation stimulates cytokine production in the epidermis of mice. J Clin Invest. 1992;90:482-7, doi: 10.1172/JCI115884.
13. Kock A, Schwarz T, Kirnbauer R, Urbanski A, Perry P, Ansel JC. Human keratinocytes are a source for tumor necrosis factor alpha: evidence for synthesis and release upon stimulation with endotoxin or ultraviolet light. J Exp Med. 1990;148:3072-8.
14. Ansel J, Perry P, Brown J, Damm D, Phan T, Hart C. Cytokine modulation of keratinocyte cytokines. J Invest Dermatol. 1990;94(Suppl):S101-7, doi: 10.1111/1523-1747.ep12876053.
15. Schröder JM. Cytokine networks in the skin. J Invest Dermatol. 1995;105(Suppl):S20-4, doi: 10.1111/1523-1747.ep12315192.
16. Waage A, Bakke O. Glucocorticoids suppress the production of tumor necrosis factor by lipopolysaccharide-stimulated human monocytes. Immunology. 1988;63:299-302.
17. Zhu X, Ertel W, Ayala A, Morrison MH, Perrin MM, Chaudry IH. Chloroquine inhibits macrophage tumour necrosis factor-alpha mRNA transcription. Immunology. 1993;80:122-6.
18. Calandra T, Bernhagen J, Metz CN, Spiegel LA, Bacher M, Donnelly T, et al. MIF as a glucocorticoid-induced modulator of cytokine production. Nature. 1995;377:68-71, doi: 10.1038/377068a0.
19. Coral GL, Kaplan G. Immunomodulation by thalidomide and thalidomide analogues. Ann Rheum Dis. 1999;58(Suppl):S1107-13, doi: 10.1136/ard.58.2008.i107.
20. Walchner M, Walchner M, Meurer M, Plewig G, Messer G. Clinical and immunologic parameters during thalidomide treatment of lupus erythematosus. Int J Dermatol. 2000;39:383-8.
21. Brink I, Thiele B, Burmester GR. Effects of anti-CD4 antibodies on the release of IL-6 and TNF-a in whole blood samples from patients with systemic lupus erithematosus. Lupus. 1999;8:723-30, doi: 10.1191/096120399678840882.
22. Swaak AJ, van Den Brink HG, Aarden LA. Cytokine production (IL-6 and TNF-alpha) in whole blood cell cultures of patients with systemic lupus erythematosus. Scand J Rheumatol. 1996;25:233-8, doi: 10.3109/03009749609069992.